These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35998960)

  • 21. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in Tanzania.
    Mbelele PM; Aboud S; Mpagama SG; Matee MI
    BMC Infect Dis; 2017 Dec; 17(1):808. PubMed ID: 29284421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.
    Van Rie A; Page-Shipp L; Hanrahan CF; Schnippel K; Dansey H; Bassett J; Clouse K; Scott L; Stevens W; Sanne I
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):368-72. PubMed ID: 23407225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    Kaso AW; Hailu A
    PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Mycobacterium tuberculosis in paucibacillary sputum: performances of the Xpert MTB/RIF ultra compared to the Xpert MTB/RIF, and IS6110 PCR.
    Kolia-Diafouka P; Carrère-Kremer S; Lounnas M; Bourdin A; Kremer L; Van de Perre P; Godreuil S; Tuaillon E
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):365-370. PubMed ID: 31005403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xpert®MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation.
    Oxlade O; Sugarman J; Alvarez GG; Pai M; Schwartzman K
    PLoS One; 2016; 11(3):e0150119. PubMed ID: 26990299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda.
    Andama A; Jaganath D; Crowder R; Asege L; Nakaye M; Katumba D; Mukwatamundu J; Mwebe S; Semitala CF; Worodria W; Joloba M; Mohanty S; Somoskovi A; Cattamanchi A
    BMC Infect Dis; 2021 Jan; 21(1):49. PubMed ID: 33430790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with genexpert MTB/RIF.
    Phuong NTB; Anh NT; Van Son N; Sintchenko V; Ho J; Fox GJ; Nhung NV; Marks GB
    BMC Infect Dis; 2019 Apr; 19(1):347. PubMed ID: 31029099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
    Vassall A; van Kampen S; Sohn H; Michael JS; John KR; den Boon S; Davis JL; Whitelaw A; Nicol MP; Gler MT; Khaliqov A; Zamudio C; Perkins MD; Boehme CC; Cobelens F
    PLoS Med; 2011 Nov; 8(11):e1001120. PubMed ID: 22087078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
    PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    Bunyasi EW; Tameris M; Geldenhuys H; Schmidt BM; Luabeya AK; Mulenga H; Scriba TJ; Hanekom WA; Mahomed H; McShane H; Hatherill M
    PLoS One; 2015; 10(11):e0141623. PubMed ID: 26554383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.
    Langley I; Lin HH; Egwaga S; Doulla B; Ku CC; Murray M; Cohen T; Squire SB
    Lancet Glob Health; 2014 Oct; 2(10):e581-91. PubMed ID: 25304634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
    Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
    Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.